U.S. Markets open in 15 hrs, 51 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,387.61 | 936.42 | 11.08% |
| NASDAQ | 1,844.25 | 194.74 | 11.81% |
| S&P 500 | 1,003.35 | 104.13 | 11.58% |
| Day Low 09:36 AM EDT | 0.49 | |
|---|---|---|
| Day High 10:49 AM EDT | 0.65 |
|
| Range | 0.16 | |
| Volume | 16,389 | |
| 30-Day Avg. Vol. | — |
|
| Difference | — | |
| Market Cap. | 21.67 M | |
| Change | 4.67 M | |
| Shares Out. | 42.49 M | |
| Percent Traded | 0.04% | |
| Revenue (LFY) | — | |
| Earnings (TTM) | — | |
| Next Earnings | 10/29/2008 |
|
| EPS (TTM) | 4.87 |
| 52-Wk Low 10/10/08 | 0.38 | |
|---|---|---|
| 52-Wk High 11/5/07 | 2.96 |
|
| Range | 2.58 | |
| Prev. Close 10/10/08 | 0.40 | |
| Today's Open | 0.49 | |
| Change | 22.50% | |
| Dividend (TTM) | — | |
| Div. Yield (TTM) | — |
|
| Beta | 1.9307 | |
| P/E Ratio (TTM) | 0.10 | |
| P/E Ratio (Fwd.) | — |
Northwest Biotherapeutics wants to bring out the killer in you. The development-stage firm's DCVax vaccine platform uses dendritic cells (a type of white blood cells) obtained from a patient's blood to ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | — 3/31/08 | -0.13 3/31/08 |
—
—
|
| Last Quarter | — 6/30/08 | -0.14 6/30/08 |
—
—
|
| Quarterly - | Annual - | |
|---|---|---|
| Total Revenue | — | — |
| Gross Profit | — | — |
| Operating Income | — | — |
| Net Income | — | — |
